Edward Kim
Walker (United States)(US)UC Davis Comprehensive Cancer CenterUniversity of California, Davis(US)The University of Texas at Austin(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer(2018)1,064 cited
- → Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis(2017)481 cited
- → Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study(2017)324 cited
- → Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma(2014)304 cited
- → NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021(2020)297 cited
- → Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study(2020)233 cited